Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

SELL
$0.14 - $4.8 $29,791 - $1.02 Million
-212,794 Reduced 61.38%
133,868 $20,000
Q2 2022

Aug 04, 2022

SELL
$0.88 - $1.73 $17,936 - $35,260
-20,382 Reduced 5.55%
346,662 $305,000
Q1 2022

May 05, 2022

SELL
$1.14 - $2.09 $9 - $16
-8 Reduced -0.0%
367,044 $455,000
Q4 2021

Feb 02, 2022

BUY
$1.67 - $2.76 $388,907 - $642,746
232,879 Added 173.57%
367,052 $716,000
Q3 2021

Nov 02, 2021

SELL
$2.62 - $3.45 $77,884 - $102,558
-29,727 Reduced 18.14%
134,173 $368,000
Q2 2021

Aug 02, 2021

BUY
$1.96 - $3.15 $321,244 - $516,285
163,900 New
163,900 $516,000

Others Institutions Holding VTGN

# of Institutions
1
Shares Held
27.1K
Call Options Held
0
Put Options Held
0

About VistaGen Therapeutics, Inc.


  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $517M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.